MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.gim.2024.101069

Медицинская библиотека · Genetics in medicine : official journal of the American College of Medical Genetics · 2024

Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada.

Regier Dean A, Loewen Rosalie, Chan Brandon, Ehman Morgan, Pollard Samantha, Friedman Jan M, Stockler-Ipsiroglu Sylvia, van Karnebeek Clara, Race Simone, Elliott Alison M, Dragojlovic Nick, Lynd Larry D, Weymann Deirdre

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

PURPOSE: To determine real-world diagnostic rates, cost trajectories, and cost-effectiveness of exome sequencing (ES) and genome sequencing (GS) for children with developmental and/or seizure disorders in British Columbia, Canada.

METHODS

Based on medical records review, we estimated real-world costs and outcomes for 491 patients who underwent standard of care (SOC) diagnostic testing at British Columbia Children's Hospital. Results informed a state-transition Markov model examining cost-effectiveness of 3 competing diagnostic strategies: (1) SOC with last-tier access to ES, (2) streamlined ES access, and (3) first-tier GS.

RESULTS

Through SOC, 49.4% (95% CI: 40.6, 58.2) of patients were diagnosed at an average cost of C$11,683 per patient (95% CI: 9200, 14,166). Compared with SOC, earlier ES or GS access yielded similar or improved diagnostic rates and shorter times to genetic diagnosis, with 94% of simulations demonstrating cost savings for streamlined ES and 60% for first-tier GS. Net benefit from the perspective of the health care system was C$2956 (95% CI: -608, 6519) for streamlined ES compared with SOC.

CONCLUSION

Using real-world data, we found earlier access to ES may yield more rapid genetic diagnosis of childhood developmental and seizure disorders and cost savings compared with current practice in a Canadian health care system.

Для цитирования: Regier Dean A, Loewen Rosalie, Chan Brandon, Ehman Morgan, Pollard Samantha, Friedman Jan M, Stockler-Ipsiroglu Sylvia, van Karnebeek Clara, Race Simone, Elliott Alison M, Dragojlovic Nick, Lynd Larry D, Weymann Deirdre. Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada.. Genetics in medicine : official journal of the American College of Medical Genetics. 2024. DOI: 10.1016/j.gim.2024.101069.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.